Skip to content
Clinical Trials – home

Follicular lymphoma stage IV Basic Information

0 / 1 trials open to patients5 countries

In short

Follicular lymphoma stage IV represents the most advanced form of this slow-growing blood cancer, where cancerous cells have spread beyond the lymphatic system into organs such as the liver, bone marrow, or lungs. While this diagnosis can feel overwhelming, many patients live for years with proper management and support, and ongoing advances in treatment continue to improve long-term outcomes.

Key points

  • Stage IV follicular lymphoma represents the most advanced stage where cancer has spread beyond lymph nodes to organs like bone marrow, liver, or lungs, yet it remains a slow-growing disease that can be managed for many years.
  • Most patients are diagnosed at stage III or IV because follicular lymphoma often causes no symptoms in early stages, making painless swollen lymph nodes the most common first sign.
  • About 85 percent of cases involve spontaneous chromosomal changes during a person's lifetime that aren't inherited, meaning family members aren't at increased risk.
  • The condition primarily affects adults over age 60, is more common in white populations, and shows a slight predominance in women.
  • While stage IV follicular lymphoma is generally not curable, many patients live for years with proper treatment, and new therapies continue to improve survival rates and quality of life.
  • Bone marrow involvement occurs in more than half of all follicular lymphoma patients at diagnosis, which can lead to anemia, increased infection risk, and bleeding problems.
  • Treatment may not be necessary immediately if symptoms aren't present—a "watchful waiting" approach called active surveillance is sometimes recommended, with treatment beginning only when symptoms develop.
  • Quitting smoking and maintaining adequate vitamin D levels may improve outcomes, as studies show both factors can influence disease progression and treatment success.

Understanding Follicular Lymphoma Stage IV

Follicular lymphoma is a type of non-Hodgkin lymphoma, which is cancer that affects the lymphatic system. The lymphatic system is a network of vessels, organs, and tissues that work together as part of your immune system to fight infections and diseases. Follicular lymphoma is the second most common type of non-Hodgkin lymphoma, with approximately 15,000 to 20,000 new cases diagnosed in the United States each year.

Stage IV follicular lymphoma means that the cancer has spread beyond the lymph nodes into one or more organs outside the lymphatic system. This could include your bone marrow (the soft tissue inside bones where blood cells are made), liver, lungs, or other organs. Despite being the most advanced stage, follicular lymphoma is typically an indolent or slow-growing cancer. This characteristic means that while the disease may not be curable, it can often be managed over many years.

Most people with follicular lymphoma are diagnosed at stage III or IV because the condition often doesn't cause noticeable symptoms in its early stages. By the time symptoms appear or enlarged lymph nodes are discovered, the cancer has typically already spread to multiple locations in the body.

How Common Is Stage IV Follicular Lymphoma

Follicular lymphoma accounts for about 10 to 20 percent of all lymphomas diagnosed in Western countries. In the United Kingdom, around 2,300 people are diagnosed with follicular lymphoma each year, making it the most common type of slow-growing lymphoma. Out of all people with non-Hodgkin lymphoma in the UK, approximately 20 percent have follicular lymphoma.

This condition mainly affects adults over the age of 60, with the median age at diagnosis being around 60 years old. There is a slight predominance in women compared to men. People who are white receive this diagnosis more often than people of other races.

Because follicular lymphoma often develops without causing symptoms early on, the majority of patients are diagnosed when the disease has already reached stage III or stage IV. Bone marrow involvement is present in more than 50 percent of patients at the time of diagnosis.

What Causes Follicular Lymphoma

Researchers do not know the exact cause of follicular lymphoma. What they do understand is that changes occur in people's chromosomes in about 85 percent of cases. These genetic changes happen at some point during a person's lifetime and are not inherited from parents.

These chromosomal changes transform normal B cells, a type of white blood cell that normally makes antibodies to fight infections, into cancer cells. Unlike healthy B cells that perform their protective function properly, these cancer cells don't work correctly. Instead, they multiply and grow out of control. Eventually, the abnormal cells may build up in lymph nodes or spread to other organs, where they can cause symptoms.

The abnormal B cells typically develop in clumps called follicles inside lymph nodes, which is why the condition is named "follicular" lymphoma. While the disease usually grows slowly, there is a small chance it can progress to a more aggressive cancer called diffuse large B-cell lymphoma.

Risk Factors for Follicular Lymphoma

Several factors can increase the likelihood of developing follicular lymphoma, though having these risk factors doesn't mean someone will definitely develop the disease. Age is one of the most significant risk factors. People aged 65 and older are more likely to develop this condition.

Race also plays a role in risk. White individuals are diagnosed with follicular lymphoma more frequently than people of other racial backgrounds. Studies have also shown that smoking cigarettes increases the risk of developing follicular lymphoma and can also increase the chances of dying from the disease.

While children can develop follicular lymphoma, it's so different from the adult form that researchers consider it a separate type of cancer. Unlike the adult version, pediatric follicular lymphoma is often curable.

Symptoms of Stage IV Follicular Lymphoma

One of the challenging aspects of follicular lymphoma is that you can have the disease without experiencing any symptoms at all. Many people discover they have the condition only after a routine check-up or when investigating an unrelated health concern.

When symptoms do appear, the most common is painless swelling in the neck, armpit, or groin area. This swelling is caused by enlarged lymph nodes, which are small bean-shaped structures that are part of your immune system. The clinical presentation is usually characterized by painless swelling of these peripheral lymph nodes in the cervical (neck), axillary (armpit), inguinal (groin), and femoral (upper thigh) regions. Sometimes, these lymph nodes can have a waxing and waning pattern, meaning they get larger and smaller over time.

Patients with stage IV follicular lymphoma often present with a combination of localized and systemic symptoms. As the disease spreads to organs like the liver or bone marrow, symptoms may expand to include fatigue, anemia (low red blood cell count), and increased susceptibility to infections.

Other general symptoms that may occur include:

  • Extreme tiredness or fatigue that doesn't improve with rest
  • Fever that comes and goes without an obvious cause like an infection
  • Heavy sweating at night, often enough to soak your bedclothes
  • Chills or unexplained temperature changes
  • Unexplained weight loss, particularly losing 10 percent or more of your body weight within the past six months

Doctors refer to fever, night sweats, and significant weight loss as "B symptoms." It's important to tell your doctor about any of these symptoms if you experience them.

In stage IV, the disease has a higher tumor burden, meaning there is more cancer in the body. Some people may develop fluid accumulation in the chest or abdomen. When follicular lymphoma affects the bone marrow, it can lead to low red blood cell counts (anemia) causing tiredness or breathlessness, or low platelet counts, causing bruising or bleeding problems.

It's important to understand the difference between symptoms caused by the cancer itself and those triggered by a compromised immune system. Identifying these symptoms early can help improve overall disease management and quality of life.

Prevention and Early Detection

Unfortunately, because the exact cause of follicular lymphoma is not known, there are no proven ways to prevent the disease. The chromosomal changes that lead to follicular lymphoma happen spontaneously during a person's life, and we don't currently have ways to prevent these changes from occurring.

However, there are some lifestyle factors that can help reduce risk or improve outcomes. Studies have shown that smoking cigarettes puts people at higher risk for follicular lymphoma and also raises the chances of dying from the disease. Quitting smoking is an important step for overall health and may reduce lymphoma risk.

Maintaining overall good health through a balanced diet, regular physical activity, and avoiding exposure to harmful chemicals may contribute to a stronger immune system, though these measures have not been specifically proven to prevent follicular lymphoma.

Since there is no screening test for follicular lymphoma, early detection typically happens when someone notices painless swelling of lymph nodes or when a doctor feels enlarged lymph nodes during a routine physical examination. If you notice any persistent lumps or swelling in your neck, armpit, or groin area, or if you experience any of the symptoms described earlier, it's important to see your doctor for evaluation.

One study found that people with low vitamin D levels before follicular lymphoma treatment didn't do as well and were more likely to relapse quicker than those with healthy levels of vitamin D. Therefore, checking vitamin D levels and maintaining adequate levels through diet, supplements, or sun exposure may be beneficial, though this should be discussed with a healthcare provider.

How the Body Changes in Stage IV Follicular Lymphoma

In follicular lymphoma, the lymphatic system, which is normally responsible for fighting infections and maintaining fluid balance in the body, becomes affected by cancerous B cells. These abnormal cells are lymphocytes that have developed in the wrong way. Unlike healthy B lymphocytes that produce antibodies to protect against infections, these cancer cells multiply without control and don't perform their protective function.

The name "follicular" comes from the fact that these abnormal B cells typically form clumps called follicles within lymph nodes. In stage IV, these cancer cells have moved beyond just the lymph nodes and have spread to other organs in the body, such as the bone marrow, liver, or lungs.

When follicular lymphoma affects the bone marrow, it can interfere with the normal production of blood cells. The bone marrow is where all blood cells are made, including red blood cells that carry oxygen, white blood cells that fight infection, and platelets that help blood clot. If cancer cells crowd the bone marrow, there may not be enough room for healthy blood cells to develop properly. This can lead to anemia (low red blood cell count), increased risk of infections (due to low white blood cell count), and easy bruising or bleeding (due to low platelet count).

Follicular lymphoma is typically an indolent or low-grade form of lymphoma, meaning it grows slowly over time. However, in some cases, the disease can behave more aggressively. Some patients with stage IV disease remain stable for years, while others may experience rapid progression or transformation into a more aggressive lymphoma, such as diffuse large B-cell lymphoma. This transformation changes the disease's behavior significantly, requiring more intensive treatment approaches.

The immune system overall becomes weakened in follicular lymphoma. Because the cancer affects the lymphatic system, which is a crucial part of immune defense, patients become more susceptible to infections. The body's ability to recognize and fight off bacteria, viruses, and other harmful organisms is reduced. This is why patients with follicular lymphoma need to be careful about protecting themselves from germs and infections.

Did you know?

  1. Follicular lymphoma can show a "waxing and waning" pattern where lymph nodes get bigger and smaller over years before diagnosis, which is unusual for most cancers.
  2. About 85 percent of follicular lymphoma cases involve specific chromosomal changes that transform normal B cells into cancer cells, yet this condition is not inherited and cannot be passed to children.
  3. Childhood follicular lymphoma is considered a completely different disease from adult follicular lymphoma and is often curable, unlike the adult form which is typically managed as a chronic condition.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Follicular lymphoma stage IV

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Celgene Corp.
See all 1 trials →filters applied: condition = Follicular lymphoma stage IV

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).